AKT1 and polycystic ovary syndrome: Moreover, the abnormalities in insulin receptor and insulin-signaling pathways could contribute to the development of IR in PCOS patients, which could be indicated by the suppression of the PI3K-Akt signaling and the extreme instigation of the MAPK signaling pathways.